SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Novartis Signs Antibody-Drug Conjugates Deal With OBI Pharma

Novartis signed a collaboration and license agreement with OBI Pharma for antibody-drug conjugates.

NVS

Related stories